Korea Stephen Yoo highlights the pioneering work that STCube Pharmaceuticals – a US subsidiary of Korean firm STCube – is undertaking in the immuno-oncology field, its three technology platforms, partnership approach, and his outlook for the company’s future. Immuno-oncology has revolutionized cancer therapy, but despite the huge success there has…
See our Cookie Privacy Policy Here